The present study demonstrates strong evidence that VCX a) induces human triple-negative breast cancer MDA-MB-231 cell growth inhibition through apoptosis, cell cycle arrest, autophagy-associated cell death, and oxidative stress mechanisms and b) increases the chemosensitivity to DOX in MDA-MB-231 cells. Here, VCX is linked to triple-negative breast carcinoma.